National Healthcare Properties, Inc. closed a registered underwritten public offering of 38,500,000 shares of Class A common stock, followed by the underwriters’ exercise of an option for 5,775,000 additional shares to cover overallotments. The option shares closing completed on April 28, 2026.
In connection with the offering, the company entered into an Amended and Restated Agreement of Limited Partnership for its operating partnership. This reset the OP Unit exchange factor to 1.0, eliminated Class B Units, removed a crystallized special interest, and created new LTIP Unit classes.
The board also approved listing-related equity awards under the 2025 Omnibus Incentive Compensation Plan. Employees, including named executive officers, received an aggregate 995,994 shares and LTIP Units vesting in 25% annual increments from April 30, 2027. The CEO, CFO and CAO were granted 348,665, 149,428 and 25,000 LTIP Units, respectively, and each director was authorized 12,500 restricted shares and/or LTIP Units.
National Healthcare Properties, Inc. Schedule 13G reports that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each disclose shared voting and dispositive power over 1,912,863 shares of Class A Common Stock, representing 4.3% of the class. The cover notes the reporting persons briefly exceeded a 5% threshold on 04/22/2026 and ceased to be beneficial owners above 5% by the filing date.
The filing lists issuer headquarters at 540 Madison Avenue, New York, and includes a Joint Filing Agreement dated April 28, 2026. Signatures are provided by Gil Raviv and Israel A. Englander.
National Healthcare Properties, Inc. entered into an Underwriting Agreement and closed a registered underwritten public offering of 38,500,000 shares of its Class A common stock under an effective Form S-11 registration statement. On April 24, 2026, the underwriters exercised their option to purchase an additional 5,775,000 shares to cover overallotments, with that closing expected on April 28, 2026. The agreement with Wells Fargo Securities, Morgan Stanley, BMO Capital Markets and other underwriters includes customary representations, covenants, indemnification and termination provisions.